You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Frataxin antibody [18A5DB1 ] (ab110328)

MSCatalog No. MSF01

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-Frataxin antibody [18A5DB1 ]
See all Frataxin products (7) ...

Description

Mouse monoclonal [18A5DB1 ] to Frataxin

Tested applications

WB, ICC/IF, Flow Cytmore details

Cross reactivity

Reacts with

Human

Immunogen

Recombinant full length mature protein, corresponding to amino acids 56-210 of Human Frataxin.

Positive control

Recombinant Human Frataxin; normal Human fibroblasts (MRC5); HL60 cells.

Properties

Form

Liquid

Storage instructions

Store at +4°C. Do not freeze.

Storage buffer

Preservative: 0.02% Sodium azide
Constituent: HBS

Concentration

Concentration information loading...

Purity

IgG fraction

Purification notes

ab110328 was produced in vitro using hybridomas grown in serum-free medium, and then purified by biochemical fractionation.

Clonality

Monoclonal

Clone number

18A5DB1

Isotype

IgG1

Light chain type

kappa

  • Western blot - Frataxin antibody [18A5DB1 ] (ab110328)Western blot - Frataxin antibody [18A5DB1 ] (ab110328) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - Anti-Frataxin antibody [18A5DB1 ] (ab110328)Immunocytochemistry/ Immunofluorescence - Anti-Frataxin antibody [18A5DB1 ] (ab110328) image (enlarge)

  • Flow Cytometry - Frataxin antibody [18A5DB1 ] (ab110328)Flow Cytometry - Frataxin antibody [18A5DB1 ] (ab110328) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab110328 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Promotes the biosynthesis of heme and assembly and repair of iron-sulfur clusters by delivering Fe(2+) to proteins involved in these pathways. May play a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe(2+) to Fe(3+); the oligomeric form but not the monomeric form has in vitro ferroxidase activity. May be able to store large amounts of iron in the form of a ferrihydrite mineral by oligomerization; however, the physiological relevance is unsure as reports are conflicting and the function has only been shown using heterologous overexpression systems. Modulates the RNA-binding activity of ACO1.

Tissue specificity

Expressed in the heart, peripheral blood lymphocytes and dermal fibroblasts.

Involvement in disease

Defects in FXN are the cause of Friedreich ataxia (FRDA) [MIM:229300]. FRDA is an autosomal recessive, progressive degenerative disease characterized by neurodegeneration and cardiomyopathy it is the most common inherited ataxia. The disorder is usually manifest before adolescence and is generally characterized by incoordination of limb movements, dysarthria, nystagmus, diminished or absent tendon reflexes, Babinski sign, impairment of position and vibratory senses, scoliosis, pes cavus, and hammer toe. In most patients, FRDA is due to GAA triplet repeat expansions in the first intron of the frataxin gene. But in some cases the disease is due to mutations in the coding region.

Sequence similarities

Belongs to the frataxin family.

Post-translational
modifications

Processed in two steps by mitochondrial processing peptidase (MPP). MPP first cleaves the precursor to intermediate form and subsequently converts the intermediate to yield frataxin mature form (frataxin(81-210)) which is the predominant form. The additional forms, frataxin(56-210) and frataxin(78-210), seem to be produced when the normal maturation process is impaired; their physiological relevance is unsure.

Cellular localization

Cytoplasm. Mitochondrion. PubMed:18725397 reports localization exclusively in mitochondria.

Target information above from: UniProt accessionQ16595 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • X25 antibody
  • CyaY antibody
  • d-FXN antibody
  • FA antibody
  • FARR antibody
  • Frataxin mature form antibody
  • Frataxin(81-210) antibody
  • FRDA antibody
  • FRDA_HUMAN antibody
  • Friedreich ataxia protein antibody
  • Fxn antibody
  • i-FXN antibody
  • m56-FXN antibody
  • m78-FXN antibody
  • m81-FXN antibody
  • MGC57199 antibody
  • MSF01 antibody
  • MSF31 antibody
  • MSF42 antibody
see all

Anti-Frataxin antibody [18A5DB1 ] images:

  Western blot - Frataxin antibody [18A5DB1 ] (ab110328)

Western blot - Frataxin antibody [18A5DB1 ] (ab110328)

Anti-Frataxin antibody [18A5DB1 ] (ab110328) at 5 µg/ml + Recombinant Human Frataxin at 0.0005 µg

Predicted band size : 23 kDa

  Immunocytochemistry/ Immunofluorescence - Anti-Frataxin antibody [18A5DB1 ] (ab110328)

Immunocytochemistry/ Immunofluorescence - Anti-Frataxin antibody [18A5DB1 ] (ab110328)

Immunocytochemistry analysis using ab110328 at 0.5µg/ml staining Frataxin in normal Human fibroblasts (MRC5) (fixed and permeabilized) followed by an AlexaFluor® 594-conjugated-goat-anti-mouse IgG1 isotype specific secondary antibody (2 µg/ml). .

  Flow Cytometry - Frataxin antibody [18A5DB1 ] (ab110328)

Flow Cytometry - Frataxin antibody [18A5DB1 ] (ab110328)

Flow cytometric analysis using ab110328 at 1µg/ml staining Frataxin in HL60 cells (blue). Isotype control antibody (red).

References for Anti-Frataxin antibody [18A5DB1 ] (ab110328)

This product has been referenced in:

  • Selak MA  et al. Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function. Mitochondrion 11:342-50 (2011).Read more (PubMed: 21147271) »
  • Koeppen AH  et al. The neuropathology of late-onset Friedreich's ataxia. Cerebellum 10:96-103 (2011).Read more (PubMed: 21128039) »

See all 10 publications for this product

Publishing research using ab110328? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"